Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0SG9Q
|
|||
Drug Name |
US9388139, 12
|
|||
Synonyms |
SCHEMBL12493454; CHEMBL3899621; BDBM236643; US9388139, 12
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C20H20Cl2N2O2
|
|||
Canonical SMILES |
CC(C)(C)C1=NN(C(C1)C2=C(C=C(C=C2)Cl)Cl)C3=CC=C(C=C3)C(=O)O
|
|||
InChI |
1S/C20H20Cl2N2O2/c1-20(2,3)18-11-17(15-9-6-13(21)10-16(15)22)24(23-18)14-7-4-12(5-8-14)19(25)26/h4-10,17H,11H2,1-3H3,(H,25,26)
|
|||
InChIKey |
DIZHQHRVPINGBC-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Phosphodiesterase 3B (PDE3B) | Target Info | Inhibitor | [1] |
Target's Patent Info | Phosphodiesterase 3B (PDE3B) | Target's Patent Info | [1] | |
NetPath Pathway | TCR Signaling Pathway | |||
IL2 Signaling Pathway | ||||
Pathway Interaction Database | Class IB PI3K non-lipid kinase events |
References | Top | |||
---|---|---|---|---|
REF 1 | Derivatives of celeboxib, use thereof and preparation thereof. US9388139. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.